Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Fluidigm, DVS Sciences; Sigma-Aldrich; HTG Molecular Diagnostics; Invisible Sentinel; InstantLabs

NEW YORK (GenomeWeb News) – Fluidigm said this week it has completed its $207.5 million buy of mass cytometry firm DVS Sciences. Principally operating in Sunnyvale, Calif., DVS is now a wholly owned subsidiary of Fluidigm. The acquisition adds a high-parameter single-cell protein analysis platform to Fluidigm's single-cell genomics platform "to create a comprehensive portfolio of advanced technologies serving the rapidly growing single-cell genomics and proteomics markets," it said.


Sigma-Aldrich's board approved a 7 percent increase to the firm's quarterly cash dividend to $.23 per share. The increased dividend is payable on March 14 to shareholders of record at the close of business on Feb. 28.


HTG Molecular Diagnostics said in a document filed with the US Securities and Exchange Commission that it raised $7.5 million toward a targeted $21.7 million round of private financing. The company said earlier this week it completed a Series E preferred stock offering, but declined to disclose the amount of the raise.


The Association of Analytical Communities (AOAC) has certified Invisible Sentinel's Veriflow Listeria species assay for detecting bacterial contamination by Listeria species in various food types, including ready-to-eat foods, deli meat, and dairy products, and on various surfaces. The technology detects molecular targets to "enable food processors access to rapid, practical, and easily implemented food safety diagnostics," according to the company's website.


Molecular diagnostic firm InstantLabs has received AOAC certification for its InstantLabs Food Safety Kit for E. coli O157 (including H7). The PCR-based kit provides results from enriched samples in less than two hours, with enrichment times as short as 10 hours, the Baltimore-based company said.


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Filed under